Health Care Archives - Page 6 of 478

2 minute read

ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential

June 7, 10:42 AM

New ETFs focusing on weight-loss drugs have launched. However, industry observers caution about their long-term prospects and the concentrated risks associated with these investments.

LLY

2 minute read

AbbVie’s Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability

By Vandana Singh

June 7, 10:39 AM

Humira maintains over 80% of its market share despite facing nine biosimilar rivals, raising concerns about the future of the biosimilar market and prompting calls for regulatory reform to enhance patient access and incentivize development.

ABBV

2 minute read

Ozempic, Wegovy Create Domino Effect As New Products Emerge Across Industries To Capture New Consumer Habits

By Benzinga Neuro

June 7, 10:17 AM

Companies from food and beverage to fitness are adapting to the increased demand for these drugs, hoping to capitalize on shifting consumer habits

LLY

2 minute read

FDA Approves Geron’s First Commercial Drug, Competes With Bristol Myers Squibb’s Blood Cancer Drug

By Vandana Singh

June 7, 9:49 AM

FDA approves Geron's Rytelo (imetelstat) for adults with low-to intermediate-1 risk myelodysplastic syndromes and transfusion-dependent anemia Geron's first commercial treatment targets a market potential of $1.2 billion.

BMY

2 minute read

Venus Concept Stock Soars 127% Premarket After Regaining Nasdaq Compliance

By Benzinga Neuro

June 7, 6:47 AM

As part of the compliance, Venus Concept will be under a mandatory panel monitor until June 4, 2025.

VERO

2 minute read

This Pharma Stock Dropped 60% Premarket As FDA Halted Diabetes Drug Trials

By Benzinga Neuro

June 7, 6:20 AM

Elevated liver enzyme levels were noted, although most adverse events were mild to moderate, with no severe reactions reported.

BMEA

2 minute read

First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map

By Natan Ponieman

June 6, 2:21 PM

Moderna shares are up almost 29% this month; CureVac is up 72% in the past month; and Novavax spiked 317% in the past month.

CVAC

2 minute read

Some Breather For E-Cigarette Maker Juul As FDA Reconsiders Marketing Denials Issued Two Years Ago

By Vandana Singh

June 6, 2:08 PM

FDA rescinds marketing denial orders for JUUL Labs Inc., pending further review. Recent case law influences decision. FDA seeks scientific soundness in e-cigarette approval process. JUUL's financial woes continue amid regulatory uncertainty.

2 minute read

Italy Probes European Pharma Giants Novartis, Roche Over Eye Drug Competition Allegations

By Vandana Singh

June 6, 1:19 PM

Italy's antitrust authority is investigating Novartis and Roche's Genentech for allegedly delaying the Italian market launch of Byooviz, a Samsung Bioepis biosimilar of Lucentis.

NVS

1 minute read

AbbVie’s Immunogen Acquired Elahere Meets Primary Goal In Mid-Stage Study In Heavily Pretreated Ovarian Cancer Patients

By Vandana Singh

June 6, 1:02 PM

AbbVie announced Phase 2 PICCOLO trial results for Elahere in heavily pre-treated ovarian cancer patients. The trial achieved a 51.9% objective response rate.

ABBV